UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study

Clinical cancer research, 2018-06, Vol.24 (12), p.2771-2779

2018

Volltextzugriff (PDF)

Risk Stratification for Second Primary Lung Cancer

Journal of clinical oncology, 2017-09, Vol.35 (25), p.2893-2899

2017

Volltextzugriff (PDF)

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

Journal of clinical oncology, 2019-02, Vol.37 (4), p.278-285

2019

Volltextzugriff (PDF)

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

Journal of clinical oncology, 2019-04, Vol.37 (12), p.946-953

2019

Volltextzugriff (PDF)

SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2019-01, Vol.37 (2), p.97-104

2019

Volltextzugriff (PDF)

Diffuse High Intensity PD–L1 Staining in Thymic Epithelial Tumors

Journal of thoracic oncology, 2015-03, Vol.10 (3), p.500-508

2015

Volltextzugriff (PDF)

Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes

Lung cancer (Amsterdam, Netherlands), 2019-07, Vol.133, p.144-150

2019

Volltextzugriff (PDF)

Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database

Journal of thoracic oncology, 2018-03, Vol.13 (3), p.436-446

2018

Volltextzugriff (PDF)

A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma

Journal of thoracic oncology, 2016-10, Vol.11 (10), p.1690-1700

2016

Volltextzugriff (PDF)

Osimertinib for EGFR‐Mutant Lung Cancer with Brain Metastases: Results from a Single‐Center Retrospective Study

The oncologist (Dayton, Ohio), 2019-06, Vol.24 (6), p.836-843

2019

Volltextzugriff (PDF)

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry

Journal of clinical oncology, 2017-05, Vol.35 (13), p.1403-1410

2017

Volltextzugriff (PDF)

Immunohistochemical analysis of lichenoid reactions in patients treated with anti-PD-L1 and anti-PD-1 therapy

Journal of cutaneous pathology, 2016-04, Vol.43 (4), p.339-346

2016

Volltextzugriff (PDF)

Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)

Clinical cancer research, 2016-05, Vol.22 (10), p.2386-2395

2016

Volltextzugriff (PDF)

Metabolic Tumor Burden Predicts for Disease Progression and Death in Lung Cancer

International journal of radiation oncology, biology, physics, 2007-10, Vol.69 (2), p.328-333

2007

Volltextzugriff (PDF)

Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases

Journal of neuro-oncology, 2021-03, Vol.152 (1), p.125-134

2021

Volltextzugriff (PDF)

Opportunistic Invasive Fungal Infections Mimicking Progression of Non–Small-Cell Lung Cancer

Clinical lung cancer, 2021-03, Vol.22 (2), p.e193-e200

2021

Volltextzugriff (PDF)

Determinants of Complete Resection of Thymoma by Minimally Invasive and Open Thymectomy: Analysis of an International Registry

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.129-136

2017

Volltextzugriff (PDF)

Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at Progression

Clinical lung cancer, 2021-05, Vol.22 (3), p.201-209

2021

Volltextzugriff (PDF)

A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer

Cancer chemotherapy and pharmacology, 2022-01, Vol.89 (1), p.105-115

2022

Volltextzugriff (PDF)

Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC

Journal of thoracic oncology, 2024-03, Vol.19 (3), p.500-506

2024

Volltextzugriff (PDF)

Lung cancer incidence trends by histology type among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 1990-2010

Cancer epidemiology, biomarkers & prevention, 2014-11, Vol.23 (11), p.2250-2265

2014

Volltextzugriff (PDF)

Integrating Electronic Health Record, Cancer Registry, and Geospatial Data to Study Lung Cancer in Asian American, Native Hawaiian, and Pacific Islander Ethnic Groups

Cancer epidemiology, biomarkers & prevention, 2021-08, Vol.30 (8), p.1506-1516

2021

Volltextzugriff (PDF)

Relationship of Driver Oncogenes to Long-Term Pemetrexed Response in Non–Small-Cell Lung Cancer

Clinical lung cancer, 2015-09, Vol.16 (5), p.366-373

2015

Volltextzugriff (PDF)

A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer

Cancer chemotherapy and pharmacology, 2017-05, Vol.79 (5), p.923-932

2017

Volltextzugriff (PDF)

Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer

Radiotherapy and oncology, 2017-11, Vol.125 (2), p.338-343

2017

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Aktive Filter

ThemaAged, 80 And Over

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)
Japanisch
(11)

Erscheinungsjahr

n.n

Thema

Humans
(56)
Female
(55)
Middle Aged
(55)
Aged
(54)
Male
(54)
Science & Technology
(54)
Life Sciences & Biomedicine
(53)
Oncology
(51)
Adult
(42)
Lung Neoplasms - Pathology
(26)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(20)
Lung Neoplasms - Drug Therapy
(20)
Neoplasm Staging
(20)
Carcinoma, Non-Small-Cell Lung - Pathology
(19)
Retrospective Studies
(18)
Treatment Outcome
(18)
Lung Neoplasms - Genetics
(17)
Respiratory System
(17)
Carcinoma, Non-Small-Cell Lung - Genetics
(16)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study

Risk Stratification for Second Primary Lung Cancer

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced Cancers

SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer

Diffuse High Intensity PD–L1 Staining in Thymic Epithelial Tumors

Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes

Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database

A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma

Osimertinib for EGFR‐Mutant Lung Cancer with Brain Metastases: Results from a Single‐Center Retrospective Study

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry

Immunohistochemical analysis of lichenoid reactions in patients treated with anti-PD-L1 and anti-PD-1 therapy

Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686)

Metabolic Tumor Burden Predicts for Disease Progression and Death in Lung Cancer

Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases

Opportunistic Invasive Fungal Infections Mimicking Progression of Non–Small-Cell Lung Cancer

Determinants of Complete Resection of Thymoma by Minimally Invasive and Open Thymectomy: Analysis of an International Registry

Combining Osimertinib With Chemotherapy in EGFR-Mutant NSCLC at Progression

A phase 1b study of erlotinib and momelotinib for the treatment of EGFR-mutated, tyrosine kinase inhibitor-naive metastatic non-small cell lung cancer

Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC

Lung cancer incidence trends by histology type among Asian American, Native Hawaiian, and Pacific Islander populations in the United States, 1990-2010

Integrating Electronic Health Record, Cancer Registry, and Geospatial Data to Study Lung Cancer in Asian American, Native Hawaiian, and Pacific Islander Ethnic Groups

Relationship of Driver Oncogenes to Long-Term Pemetrexed Response in Non–Small-Cell Lung Cancer

A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer

Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer

Aktive Filter

Suchergebnisse filtern